Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,042 | -58,759 | -32,656 | -98,333 | -72,409 |
| Depreciation Amortization | 301 | 168 | 60 | 304 | 229 |
| Accounts payable and accrued liabilities | -1,761 | 13,507 | 5,143 | 2,378 | 4,420 |
| Other Working Capital | -7,116 | 5,389 | 6,730 | 2,729 | 9,136 |
| Other Operating Activity | 9,136 | -9,240 | -993 | 11,771 | 5,799 |
| Operating Cash Flow | $-78,482 | $-48,935 | $-21,716 | $-81,151 | $-52,825 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -397 | -108 | N/A | -481 | -481 |
| Purchase Of Investment | -55,366 | -55,366 | N/A | -93,596 | N/A |
| Sale Of Investment | 67,200 | 31,900 | 15,600 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -13 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -13 |
| Investing Cash Flow | $11,437 | $-23,574 | $15,600 | $-94,077 | $-494 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -364 | -281 | -159 | -410 | -294 |
| Common Stock Issued | 80,304 | 80,169 | 170 | 89,203 | 89,180 |
| Common Stock Repurchased | N/A | N/A | N/A | -17 | -13 |
| Other Financing Activity | -6,917 | -6,917 | 0 | 0 | 0 |
| Financing Cash Flow | $73,023 | $72,971 | $11 | $88,776 | $88,873 |
| Beginning Cash Position | 38,266 | 38,266 | 38,266 | 124,718 | 124,718 |
| End Cash Position | 44,244 | 38,728 | 32,161 | 38,266 | 160,272 |
| Net Cash Flow | $5,978 | $462 | $-6,105 | $-86,452 | $35,554 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,482 | -48,935 | -21,716 | -81,151 | -52,825 |
| Capital Expenditure | -397 | -108 | N/A | -481 | -481 |
| Free Cash Flow | -78,879 | -49,043 | -21,716 | -81,632 | -53,306 |